Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “New Onset Type-1 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02801942
What this trial is testing

Immune Profile in Subjects With New Onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
GlaxoSmithKline 22
Testing effectiveness (Phase 2)Ended earlyNCT04899271
What this trial is testing

Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.

Who this might be right for
New-onset Type 1 Diabetes
Dompé Farmaceutici S.p.A 25
Testing effectiveness (Phase 2)Ended earlyNCT00965458
What this trial is testing

Inducing Remission in Type 1 Diabetes With Alefacept

Who this might be right for
New-onset Type 1 Diabetes Mellitus
National Institute of Allergy and Infectious Diseases (NIAID) 49
Testing effectiveness (Phase 2)WithdrawnNCT01183455
What this trial is testing

A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableUnknownNCT06157736
What this trial is testing

Microbiome in the Acute Stage of New Onset Paediatric Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
University College Cork 100
Testing effectiveness (Phase 2)Looking for participantsNCT07187531
What this trial is testing

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
SAb Biotherapeutics, Inc. 159
Testing effectiveness (Phase 2)Study completedNCT02293837
What this trial is testing

Tocilizumab (TCZ) in New-onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes MellitusNew-onset Type 1 Diabetes MellitusT1DM+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 136
Not applicableLooking for participantsNCT06919029
What this trial is testing

Effect of Advanced Hybrid Closed Loop System, MiniMed 780G in Newly Diagnosed Children and Adolescents With Type 1 Diabetes on Glycemic Control and Patient Reported Outcomes Compared to Standard Insulin Therapy Historical Data (AHCL in New Onset T1D Children Study)

Who this might be right for
Diabetes Mellitus, Type I
National and Kapodistrian University of Athens 30
Testing effectiveness (Phase 2)UnknownNCT02763423
What this trial is testing

Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation for Type 1 Diabetes With Diabetic Ketoacidosis

Who this might be right for
Ketoacidosis, Diabetic
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Early research (Phase 1)Study completedNCT03624062
What this trial is testing

MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
University of Colorado, Denver 21
Early research (Phase 1)Study completedNCT00873561
What this trial is testing

Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Neurocrine Biosciences 188
Testing effectiveness (Phase 2)Study completedNCT02505893
What this trial is testing

Minimal Islet Transplant at Diabetes Onset

Who this might be right for
Diabetes Mellitus, Type 1
Ospedale San Raffaele 6
Testing effectiveness (Phase 2)Study completedNCT00146484
What this trial is testing

Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Children's Hospital of Eastern Ontario 100
Not applicableNot Yet RecruitingNCT06586632
What this trial is testing

The Steno Free Trial: AID to Adults with New-onset of Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
University of Aarhus 60
Testing effectiveness (Phase 2)WithdrawnNCT02586831
What this trial is testing

Diabetes Islet Preservation Immune Treatment

Who this might be right for
Diabetes Mellitus, Type 1HypoglycemiaAutoimmune Diseases+1 more
Camillo Ricordi and Jay Skyler
Testing effectiveness (Phase 2)Looking for participantsNCT07142252
What this trial is testing

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 66
Not applicableUnknownNCT02871089
What this trial is testing

Closed Loop From Onset in Type 1 Diabetes

Who this might be right for
Diabetes MellitusType 1 Diabetes
University of Cambridge 96
Testing effectiveness (Phase 2)Study completedNCT00730392
What this trial is testing

Etanercept in New Onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
State University of New York at Buffalo 18
Testing effectiveness (Phase 2)Study completedNCT02218619
What this trial is testing

Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Robin Goland, MD 20
Testing effectiveness (Phase 2)Study completedNCT02284009
What this trial is testing

Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 1
GlaxoSmithKline 67
Next Page